Tussionex
Asthma Drug Takes the Itch Out of Chronic Hives »
"Feb. 25, 2013 (San Antonio, Texas) -- The asthma drug Xolair appears to be a safe and effective treatment for chronic hives, a new study shows.
The results of the study were presented at a news conference here at the American Academy"...
Read the Asthma Drug Takes the Itch Out of Chronic Hives article »
Tussionex
INDICATIONS
TUSSIONEX (hydrocodone and chlorpheniramine) Pennkinetic Extended-Release Suspension is indicated for relief of cough and upper respiratory symptoms associated with allergy or a cold in adults and children 6 years of age and older.
DOSAGE AND ADMINISTRATION
It is important that TUSSIONEX (hydrocodone and chlorpheniramine) is measured with an accurate measuring device (see PRECAUTIONS, Information for Patients). A household teaspoon is not an accurate measuring device and could lead to overdosage, especially when half a teaspoon is to be measured. It is strongly recommended that an accurate measuring device be used. A pharmacist can provide an appropriate measuring device and can provide instructions for measuring the correct dose.
Shake well before using.
Adults and Children 12 Years and Older
5 mL (1 teaspoonful) every 12 hours; do not exceed 10 mL (2 teaspoonfuls) in 24 hours.
Children 6-11Years of Age
2.5 mL (½ teaspoonful) every 12 hours; do not exceed 5 mL (1 teaspoonful) in 24 hours.
This medicine is contraindicated in children under 6 years of age (see CONTRAINDICATIONS).
HOW SUPPLIED
TUSSIONEX Pennkinetic (hydrocodone polistirex and chlorpheniramine polistirex) Extended- Release Suspension is a gold-colored suspension.
NDC 53014-548-67 473 mL bottle
For Medical Information
Contact: Medical Affairs Department
Phone: (866) 822-0068
Fax: (770) 970-8859
Storage:
Shake well. Dispense in a well-closed container.
Store at 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].
TUSSIONEX (hydrocodone and chlorpheniramine) Pennkinetic Extended-Release Suspension Manufactured for: UCB, Inc. Smyrna, GA 30080. Rev. 01/2008. FDA rev date: 3/11/2008
Last reviewed on RxList: 3/19/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Tussionex Information
Tussionex - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.







